ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $17,002,000 | +86.2% | 450,863 | +34.6% | 0.05% | +74.2% |
| Q3 2019 | $9,129,000 | -10.4% | 334,964 | -11.7% | 0.03% | -6.1% |
| Q2 2019 | $10,190,000 | -6.7% | 379,531 | +0.4% | 0.03% | -8.3% |
| Q1 2019 | $10,926,000 | +0.9% | 377,916 | -6.0% | 0.04% | -10.0% |
| Q4 2018 | $10,826,000 | – | 402,002 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |